Beruflich Dokumente
Kultur Dokumente
Shaleena Theophilus
Definitions
vaccine: A vaccine is a substance stimulates an
immune response that can either prevent an
infection or create a resistance to an infection.
“herd immunity”
Estimated Herd Immunity thresholds for vaccine preventable
diseases
Prevent
Infection
Treatment
Prime Boost
HIV Genes Code Vaccine
Targets
Env: gp120 and gp41
Gag: internal structural and capsid
proteins
Pol: three replication enzymes
Subunits Combinations
Dendritic Cells
X Live attenuated HIV
DNA Vaccines
Instead of using the whole organism or its parts,
these vaccines uses the microbe’s genetic material!
Adenovirus
Step Study
MRKAd5 HIV-1 gag/pol/nef, or trivalent, vaccine, is
based on adenovirus,
Subunits Combinations
Dendritic Cells
X Live attenuated HIV
Dendritic Cell Vaccines
T Breinig, 2005
Dendritic Cell Vaccine in HIV-1 Infection
www.Clinicaltrials.gov
Immune Response to a Therapeutic HIV Vaccine
Followed by Treatment Interruption in Patients
With Acute or Recent HIV Infection
www.Clinicaltrials.gov
Safety and Tolerability of and Immune Response
to LC002, an Experimental Therapeutic Vaccine,
in Adults Receiving Anti-HIV Treatment
www.Clinicaltrials.gov
Study of the HIV gp120/NefTat/AS02A Vaccine
to Treat Individuals With Chronic HIV-1
Infection on Highly Active Antiretroviral Therapy
(HAART)
The adjuvanted protein vaccine candidate consists of three
recombinant viral antigens: the envelope glycoprotein gp120
and two regulatory proteins, Nef and Tat. The latter are
expressed as one recombinant fusion protein, NefTat. The
antigens are formulated in the proprietary AS02A adjuvant. The
goal of this trial is to assess the safety and immunogenicity of
the gp120/NefTat/AS02A vaccine in HIV-1-infected individuals.
www.Clinicaltrials.gov
Canadian Trials
Remune® is a therapeutic vaccine made from whole HIV
particles stripped of the envelope layer and sterilized. It is used
to mimic an infection to boost the immune system. The dead
virus is emulsified in an adjuvant called "incomplete Freund's
Adjuvant" (IFA), a water and mineral oil mixture that helps to
stimulate the immune system.
CTN 208
HAART alone or with Remune Vaccine followed by structured
treatment interruption in early HIV infection / observation of
recent HIV infection
CTN 203
Phase I/II Study of Remune® plus Amplivax™
CTN 173
Vaccination Before Treatment Interruption
www.hivnet.ubc.ca
Canadian HIV Vaccines Plan
http://pubs.cpha.ca/PDF/P36/23414e.pdf
http://pubs.cpha.ca/PDF/P36/23414f.pdf
Canadian HIV Vaccines Initiative
On February 20, 2007, Prime Minister Stephen Harper and Bill
Gates announced a partnership to fund the Canadian HIV
Vaccine Initiative. The project will encourage collaboration
between Canadian and international researchers and
institutions in the discovery, development, clinical trials and
manufacturing of vaccines within Canada for use globally. The
federal government is contributing up to $111 million to the
project, while the Bill and Melinda Gates Foundation will
provide additional funding in the amount of $28 million.
3 guiding principles:
1. Continue regular scientific assessments - to reflect lessons
learned, new opportunities and the influence of new discoveries
2. Establish a global process - standardization of data sharing,
communication, and convening must be established to optimize
progress at the global level.
3. Shared accountability - a culture of mutual accountability among
partners will be necessary for the effective implementation of the
scientific strategic plan.
www.hivvaccineenterprise.org/
Useful websites
www.cdnaids.ca Basics, advocacy updates
www.icaso.org Primers
www.iavi.org
www.hvtn.org
www.avac.org